ARTICLE | Management Tracks
Syndax names new commercial head
Plus: Everest hires Sandra Zeng as CMO and Rico Liang as chief product officer, and updates from Parexel, Dignify and GRO
March 19, 2024 12:48 AM UTC
Cancer company Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) hired Steven Closter to succeed Chief Commercial Officer Steve Sabus, who is departing for personal reasons. Closter was VP of brand strategy and launch excellence at Sumitomo Pharma America Inc.
Everest Medicines Ltd. (HKEX:1952) hired Sandra Zeng as CMO and Rico Liang as chief product officer. Zeng was global development program lead in hematology at the U.S. division of Bristol Myers Squibb Co. (NYSE:BMY); Liang was SVP, general manager of Greater China of Brii Biosciences Ltd. (HKEX:2137)...